Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study
This was a 1-year, double-blind, randomized, placebo-controlled pilot trial in people with mild Alzheimer’s disease. Participants took either three 350 mg capsules per day of Hericium erinaceus mycelia enriched with 5 mg/g erinacine A (about 5.25 mg erinacine A per day) or placebo for 49 weeks after a 3-week screening.…